Senzime
Senzime is a pioneering medical device company specializing in precision-based patient monitoring systems. Our mission is to safeguard every patient’s journey, from anesthesia to recovery.
Senzime Q3 2025 report presentation
Senzime - Who we are and what we do
The next-generation TetraGraph: Advancing beyond the twitch
The future of quantitative TOF monitoring: Next-generation TetraGraph
Elevating Pediatric Anesthesia: Roundtable Focused on Neuromuscular Monitoring
Expert Insights: Perspectives on the new guidelines for neuromuscular blockade management
Decreasing post surgical length of stay using minute ventilation monitoring
Webinar: Neuromuskuläre Restblockade – kein Kavaliersdelikt
Webinar: Monitoring respiratory volume in non-intubated patients: Why and how?
TetraGraph - PTC time intervals
Webinar - A true story. Awake with post-op residual paralysis
Editors Choice Anesthesiology October 2021 - Ipsilateral and Simultaneous Comparison, R Nemes et al.
TetraGraph History
Interview with Pia Renaudin, CEO Senzime, July 2021.
Webinar - Improving Advances in Neuromuscular Management, Dr Ross J. Renew
Online Seminar #1 Monitoring Incidence of Residual Block - Prof. Sorin J. Brull
Webinar - New Evidence in the Management of Neuromuscular Blockade
TetraGraph Information Video (animation)